McCann Health promotes Hilary Gentile to global chief strategy officer
McCann Health has promoted Hilary Gentile to the newly created position of global chief strategy officer.
Hilary has been with McCann Health for 20 years and served as the chief strategy officer for North America since 2015. She has extensive experience with new product launches, business planning and helping companies across the spectrum of health, wellness and pharmaceuticals. She will report to Global CEO John Cahill.
Among Gentile’s major accomplishments is the adoption of McCann Worldgroup’s Truth 2 Meaning (T2M) strategic planning process across McCann Health, the creation of the proprietary strategic tool Future-Scape and the launch of McCann’s Truth About Doctors study.
Hilary was inducted into the 2017 MM&M Hall of Femme. As one of healthcare marketing's leading strategists, she has become a trusted advisor to some of the largest pharmaceutical companies in the North American region.
